Treatment

BGB-A425 clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
This study is looking at a new treatment called tislelizumab, sometimes combined with other medicines, for head and neck cancer that has come back or spread. The aim is to see if it can shrink tumours and if it's safe for patients.
For: Head and Neck Squamous Cell Carcinoma · Head and Neck Cancer
United States · Australia · Canada